Inflammatory bowel diseases (IBD) are an example of chronic diseases affecting 40% of the
population, which involved tissue damage and an inflammatory process not satisfactorily …

Graft versus host disease (GVHD) remains a major cause of morbidity and mortality
following allogeneic hematopoietic stem-cell transplantation (HSCT). Despite the use of …

Abstract The American Society for Transplantation and Cellular Therapy (ASTCT) published
its first white paper on indications for autologous and allogeneic hematopoietic cell …

Abstract Approximately 20,000 hematopoietic cell transplantation (HCT) procedures are
performed in the United States annually. With advances in transplantation technology and …

Although transplant practices have changed over the last decades, no information is
available on trends in incidence and outcome of chronic graft-versus-host disease (cGVHD) …

Background The introduction of donors other than HLA-matched siblings has been a pivotal
change in stem cell transplantation. We aimed to assess the evolution of outcomes within …

Advances in hematopoietic cell transplantation (HCT) have led to an increasing number of
transplant survivors. To adequately support their healthcare needs, there is a need to know …

Treatment of older adults with acute myeloid leukemia (AML) or myelodysplastic syndromes
(MDS) is challenging because of disease morbidity and associated treatments. Both …

Unrelated cord blood transplantation (CBT) is an alternative curative option for adult patients
with acute myeloid leukemia (AML) who need allogeneic hematopoietic cell transplantation …

Allogeneic hematopoietic cell transplantation is widely used to treat adults with high-risk
acute lymphoblastic leukemia. The aim of this study was to analyze whether the results …